Senior insider sale
THERAVANCE BIOPHARMA, INC. — senior position signals high conviction
$1.40M
74.50K shares
What this filing means
BROSHY ERAN plans to sell 74.50K shares of THERAVANCE BIOPHARMA, INC. valued at approximately $1.40M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/26/2025ACC: 0001950047-25-009394
74.50K
Shares to sell
$1.40M
Approx. market value
29.50K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months4
Stock Option Exercise
Cash
11/26/2025
14KRestricted Stock
Not Applicable
4/30/2019
3.50KRestricted Stock
Not Applicable
5/1/2018
6KRestricted Stock
Not Applicable
4/22/2016
6KTotal acquired29.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/26/2025 | Stock Option Exercise Cash | 14K | — |
4/30/2019 | Restricted Stock Not Applicable | 3.50K | — |
5/1/2018 | Restricted Stock Not Applicable | 6K | — |
4/22/2016 | Restricted Stock Not Applicable | 6K | — |
| Total | 29.50K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
45K
Market value
$809.3K
11/11/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
29.50K
Market value
$590.0K
11/26/2025
Total
Units
74.50K
Value
$1.40M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/11/2025 | 45K | $809.3K | — | Completed |
| Planned — Approximate Date | ||||
11/26/2025 | 29.50K | $590.0K | NASDAQ | Planned |
| Total | 74.50K | $1.40M | ||